TNF-R2 expression in acquired middle ear cholesteatoma
- PMID: 21860983
- PMCID: PMC9450802
- DOI: 10.1590/S1808-86942011000400020
TNF-R2 expression in acquired middle ear cholesteatoma
Abstract
Acquired middle ear cholesteatoma is a disease which promotes bone erosion resulting in potentially serious complications. The tumor necrosis factor alpha (TNF-α) is present in cholesteatoma and it is related to bone erosion, as shown by different authors. To understand the aggressiveness characteristics of cholesteatoma is necessary, however, to better address the presence and distribution of their receptors.
Objective: To evaluate the expression of type 2 TNF-α receptor (TNF-R2) in fragments of cholesteatoma and correlate it to the degree of inflammation present.
Material and methods: observational cross-sectional study, which analyzed 33 fragments of cholesteatomas through histological analysis and immunohistochemistry (using as primary antibody to TNF-R2 LabVision® brand). The evaluation was performed by means of a qualitative and semi-quantitative agreement with the observed intensity. For statistical analysis we used the Fisher exact test and Spearman's correlation coefficient (considered statistically significant when p < 0. 05).
Results: The expression of TNF-R2 was present in all fragments, however a statistical analysis showed no correlation or association between inflammation and the expression of TNF-R2.
Conclusions: TNF-R2 is present in cholesteatoma of the middle ear, however, its expression is not directly related to the degree of inflammation observed in patients with this disease.
Figures
References
-
- Ribeiro FAQ, Pereira CSB. Tratado de Otorrinolaringologia. Editora Roca; São Paulo: 2003. Otite média crônica colesteatomatosa In: SBORL. pp. 93–102.
-
- Lim DJ, Saunders WH. Acquired cholesteatoma: light and electron microscopic observation. Ann Otol. 1972;81:2–12. - PubMed
-
- Pereira CSB. Tese (doutorado). Faculdade de Ciências Médicas da Santa Casa de São Paulo; São Paulo: 2001. Imunoexpressão da citoqueratina 16 e do antígeno nuclear Ki-67 no colesteatoma adquirido da orelha média.
-
- Kurihara A, Toshima M, Yuasa R, Takasaka T. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha. Ann Otol Rhinol Laryngol. 1991;100(12):989–998. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
